A review of life science current events reported by MedCity News this week:
Medtronic builds a healthcare mobile app for cardiac medical devices. This product lets physicians who are authorized to use the company’s remote monitoring CareLink Network to monitor patients with implantable cardiac devices get the same information on their iPhone, iPad or iPod Touch.
Pfizer-Icagen merger: What ICGN could bring to PFE’s portfolio. If Pfizer buys Icagen, it gets Icagen’s ion channel technology and pipeline for itself.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Feeding tube maker Applied Medical Technology gets FDA warning letter. The FDA cited seven specific violations it found in an April inspection of the medical device company’s Brecksville, Ohio, manufacturing facility. One specific violation the FDA cited was a failure to thoroughly investigate complaints about Applied Medical Technology’s devices.
Could NC biotech Icagen get acquired by Pfizer? Pfizer has disclosed in a regulatory filing that it has started talks with the Durham-based company. Icagen, which is also a Pfizer partner, released a brief statement acknowledging “preliminary discussions with Pfizer regarding a potential strategic transaction.”
Why the Alaina Giordano case should worry the healthcare industry. The popular assumption that Giordano’s cancer has had a major impact on this case is wrong. And healthcare professionals nationwide should be paying particular attention to what’s happening. Overemphasizing the role of cancer in this case gives a false impression of its role in legal proceedings and draws valuable attention from real issues around the disease.
